Outcome implications of the International Maternal Phenylketonuria Collaborative Study (MPKUCS): 1994.
It is well established that women with phenylketonuria who remain untreated during pregnancy face serious problems in offspring outcome. Surveys have documented that maternal phenylalanine (Phe) blood concentrations above 1200 mumol/l are associated with microcephaly, congenital heart disease and intrauterine growth retardation among their offspring. To investigate the efficacy of the Phe restricted diet, the National Institute of Child Health and Human Development in Bethesda Maryland developed an international study to evaluate fetal outcome in pregnancies treated with the Phe restricted diet. The study involves over 100 metabolic clinics in the United States, Canada and Germany, and is now in its 10th year. The results included in this report are still preliminary in nature and the actual risk for such pregnancies remains to be determined.
Koch
R
R
Childrens Hospital Los Angeles, Division of Medical Genetics, CA 90027, USA.
Levy
H
H
Hanley
W
W
Matalon
R
R
Rouse
B
B
Trefz
F
F
de la Cruz
F
F
D018753:Diet, Protein-Restricted; D005260:Female; D006801:Humans; D015337:Multicenter Studies as Topic; D017042:Phenylketonuria, Maternal / Q000178:diet therapy*; D011247:Pregnancy; D011256:Pregnancy Outcome